Pettit G R, Lippert J W, Taylor S R, Tan R, Williams M D
Cancer Research Institute and Department of Biochemistry, Arizona State University, Tempe, Arizona 85287-2404, USA.
J Nat Prod. 2001 Jul;64(7):883-91. doi: 10.1021/np0100441.
The cyclic octapeptide phakellistatin 11 (1), a constituent of The Federated States of Micronesia (Chuuk) marine sponge Phakellia sp., was synthesized using solid-phase techniques. An initial solution-phase synthesis proved to be inadequate owing to spontaneous deprotection of the Fmoc group at the heptapeptide stage. Using the PAL resin attachment and proceeding from Fmoc-Glu-alpha-allyl ester, linear elongation of the octapeptide was performed until the final unit Pro was added. The allyl ester was removed using Pd(0)P(C(6)H(5))(3). Cleavage of the final Fmoc group and cyclization with PyAOP provided phakellistatin 11 (1) in 17% overall yield. The synthetic specimen of phakellistatin 11 (1) was found to be chemically but not biologically (cancer cell lines) identical to the natural product. The result suggested a conformational difference or more likely the presence of a trace amount of a highly active antineoplastic agent that binds noncovalently to the natural cyclic octapeptide 1.
环状八肽斐克勒他汀11(1)是密克罗尼西亚联邦(楚克)海洋海绵Phakellia sp.的一种成分,采用固相技术合成。由于在七肽阶段Fmoc基团的自发脱保护,最初的溶液相合成被证明是不充分的。使用PAL树脂连接,从Fmoc-Glu-α-烯丙酯开始,进行八肽的线性延伸,直到加入最终单元Pro。使用Pd(0)P(C(6)H(5))(3)除去烯丙酯。最后一个Fmoc基团的裂解和用PyAOP环化,以17%的总收率得到斐克勒他汀11(1)。发现斐克勒他汀11(1)的合成样品在化学上与天然产物相同,但在生物学上(癌细胞系)不同。该结果表明存在构象差异,或者更可能是存在痕量的高活性抗肿瘤剂,其与天然环状八肽1非共价结合。